Working… Menu
Trial record 1 of 1 for:    64091742PCR3001
Previous Study | Return to List | Next Study

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer (MAGNITUDE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03748641
Recruitment Status : Recruiting
First Posted : November 21, 2018
Last Update Posted : October 9, 2020
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 21, 2022
Estimated Study Completion Date : February 25, 2025